To Evaluate the Safety and Pharmacokinetic Characteristics After the Administration of JT-001, JT-002 and JLP-2008
Clinical trial NCT06165965 · COMPLETED
Trial details
- NCT number
- NCT06165965
- Sponsor
- Jeil Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-03
- Primary completion
- 2022-06-13
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.